How network consortia and patient-driven advocacy groups have driven collaboration in research
The rationale behind the Myeloma UK Clinical Trial Network
The importance of multiple myeloma foundations and a patient story
Paul Richardson et al.
Why global collaborations are key in multiple myeloma
Myeloma UK as a driver of collaboration between industry and academia